<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>新药汇 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-26T13:16:42+08:00</updated>
  <subtitle>新药研发和临床试验交流和分享</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>国家药监局发布《真实世界数据用于医疗器械临床评价技术指导原则（试行）》</title>
    <updated>2020-11-26T11:24:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/5gXTJNH9N6xWhbwVG4rcnw</id>
    <link href="https://mp.weixin.qq.com/s/5gXTJNH9N6xWhbwVG4rcnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新指南《临床试验设计六大核心要素之一：人群》推荐适应性设计和富集设计</title>
    <updated>2020-11-25T16:09:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/T4jrZVrNoeV4H5NbFESXwA</id>
    <link href="https://mp.weixin.qq.com/s/T4jrZVrNoeV4H5NbFESXwA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国非公立医疗机构协会正式“加盟”！ 重磅助力2020南京国际生命健康大会暨博览会</title>
    <updated>2020-11-25T16:09:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/Y-esLahfLOoISGDT10B_yg</id>
    <link href="https://mp.weixin.qq.com/s/Y-esLahfLOoISGDT10B_yg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《疫苗临床试验抗体分析方法研究技术指导原则》征求意见稿</title>
    <updated>2020-11-25T16:09:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/2AaqgRf4xT5b4ReLUHDlnQ</id>
    <link href="https://mp.weixin.qq.com/s/2AaqgRf4xT5b4ReLUHDlnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国产「药王」新适应症获批，八成原研市场进一步被瓜分</title>
    <updated>2020-11-25T16:09:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/HQqv1g8OiNGQu5SdFnIPDA</id>
    <link href="https://mp.weixin.qq.com/s/HQqv1g8OiNGQu5SdFnIPDA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《化学药品创新药I期临床试验申请药学共性问题相关技术要求》和《化学药品I期临床试验申请药学研究信息汇总表（修订版）》</title>
    <updated>2020-11-23T15:53:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/wQn2L7tQ3l72ok8CvraLpw</id>
    <link href="https://mp.weixin.qq.com/s/wQn2L7tQ3l72ok8CvraLpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>指南 | WHO《临床试验用药GMP指南》2020征求意见稿</title>
    <updated>2020-11-23T15:53:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/p0Uoy85eGFtbG3Qzc4jjoQ</id>
    <link href="https://mp.weixin.qq.com/s/p0Uoy85eGFtbG3Qzc4jjoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“绝代双骄，联动未来” SciVario® twin双联生物反应器重磅上市，助力生物制药行业高质量发展</title>
    <updated>2020-11-23T15:53:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/83uZm9pdZKdUrf8EshD1mQ</id>
    <link href="https://mp.weixin.qq.com/s/83uZm9pdZKdUrf8EshD1mQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州「地舒单抗」新适应症获批！国内首款骨转移及骨相关事件 RANKL 抑制剂</title>
    <updated>2020-11-23T15:53:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/FBPNGJXdLbLnVGYwzB32Qw</id>
    <link href="https://mp.weixin.qq.com/s/FBPNGJXdLbLnVGYwzB32Qw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE重磅利好！药品临床期间即可申请批准！《药品附条件批准上市技术指导原则（试行）》即日执行</title>
    <updated>2020-11-20T14:26:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/UpQy88TmLkW2L-bxzEdKzQ</id>
    <link href="https://mp.weixin.qq.com/s/UpQy88TmLkW2L-bxzEdKzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布第三批临床急需境外新药名单</title>
    <updated>2020-11-20T14:26:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/Rpje6amUzdq7r9emjvg1Cw</id>
    <link href="https://mp.weixin.qq.com/s/Rpje6amUzdq7r9emjvg1Cw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝达药业「恩莎替尼」获批上市，首个国产 ALK 抑制剂</title>
    <updated>2020-11-19T15:44:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/7o1wfT-6am3bW3IESaxbug</id>
    <link href="https://mp.weixin.qq.com/s/7o1wfT-6am3bW3IESaxbug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫情终结者？ 又一新冠疫苗有效率达94.5%，又是mRNA疫苗</title>
    <updated>2020-11-19T15:44:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/PV-sQQ8LcsnJjOZpqzZwaw</id>
    <link href="https://mp.weixin.qq.com/s/PV-sQQ8LcsnJjOZpqzZwaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020第四届中国生物制药创新与前沿技术峰会 (BIFT)</title>
    <updated>2020-11-19T15:44:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/UEWRoHY6B6-41JC0lvY9nA</id>
    <link href="https://mp.weixin.qq.com/s/UEWRoHY6B6-41JC0lvY9nA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>浅谈 | 常见的临床研究设计类型</title>
    <updated>2020-11-17T14:45:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/k6Gj0az5C11bIRKvd5X2yA</id>
    <link href="https://mp.weixin.qq.com/s/k6Gj0az5C11bIRKvd5X2yA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞医药创新药SHR-1314注射液获批临床</title>
    <updated>2020-11-17T14:45:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/TCFQ2nDH2JsZ_ksEsvXPxg</id>
    <link href="https://mp.weixin.qq.com/s/TCFQ2nDH2JsZ_ksEsvXPxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>官方重磅 | 80+行业领军学者齐聚，12月千人药物创新盛会</title>
    <updated>2020-11-17T14:45:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/hqkjWwWRfkw1vH_Q6iUMXw</id>
    <link href="https://mp.weixin.qq.com/s/hqkjWwWRfkw1vH_Q6iUMXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>终版日程大公开 | WPMCS第五届全球精准医疗（中国）峰会门票优惠即将截止！</title>
    <updated>2020-11-17T14:45:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/_E3K40IQQZ3kZC5FuKAs0w</id>
    <link href="https://mp.weixin.qq.com/s/_E3K40IQQZ3kZC5FuKAs0w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>浅谈|临床试验方案偏离</title>
    <updated>2020-11-13T11:44:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/CckNRlnx57VrYEIt7JRcmQ</id>
    <link href="https://mp.weixin.qq.com/s/CckNRlnx57VrYEIt7JRcmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ADC药物：过去的十年</title>
    <updated>2020-11-13T11:44:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/BM5hG6aMJq0R5-Ipok3wOA</id>
    <link href="https://mp.weixin.qq.com/s/BM5hG6aMJq0R5-Ipok3wOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>